Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization
- 19 April 2012
- journal article
- retinal disorders
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 251 (1) , 1-7
Abstract
To investigate the long-term visual prognosis and progression of chorioretinal atrophy in patients with myopic choroidal neovascularization (mCNV) treated with intravitreal injections of bevacizumab.Keywords
This publication has 40 references indexed in Scilit:
- Intravitreal Ranibizumab for Myopic Choroidal Neovascularization: Factors Predictive of Visual Outcome and Need for RetreatmentAmerican Journal of Ophthalmology, 2011
- Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularizationEye, 2011
- TWELVE-MONTH OUTCOME AFTER ONE INTRAVITREAL INJECTION OF BEVACIZUMAB TO TREAT MYOPIC CHOROIDAL NEOVASCULARIZATIONRetina, 2010
- STERILE ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB OBTAINED FROM A SINGLE BATCHRetina, 2010
- INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATIONRetina, 2010
- INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING PATHOLOGIC MYOPIARetina, 2010
- Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisationBritish Journal of Ophthalmology, 2009
- INTRAVITREAL RANIBIZUMAB FOR THE PRIMARY TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIARetina, 2009
- Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month resultsEye, 2009
- Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularizationOphthalmology, 1999